Potential Tear Biomarkers for the Diagnosis of Parkinson's Disease-A Pilot Study

Parkinson's disease (PD) is the second most common neurodegenerative disease after Alzheimer's disease. In this study, the tear proteome profile of patients with idiopathic PD (iPD, = 24), carriers of the E46K-SNCA mutation ( = 3) and healthy control (CT, = 27) subjects was analyzed to ide...

Full description

Saved in:
Bibliographic Details
Published inProteomes Vol. 10; no. 1; p. 4
Main Authors Acera, Arantxa, Gómez-Esteban, Juan Carlos, Murueta-Goyena, Ane, Galdos, Marta, Azkargorta, Mikel, Elortza, Felix, Ruzafa, Noelia, Ibarrondo, Oliver, Pereiro, Xandra, Vecino, Elena
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 13.01.2022
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Parkinson's disease (PD) is the second most common neurodegenerative disease after Alzheimer's disease. In this study, the tear proteome profile of patients with idiopathic PD (iPD, = 24), carriers of the E46K-SNCA mutation ( = 3) and healthy control (CT, = 27) subjects was analyzed to identify candidate biomarkers for the diagnosis of PD. An observational, prospective and case-control pilot study was carried out, analyzing the participants tear samples by nano-liquid chromatography-mass spectrometry (nLC-MS/MS) and assessing their neurological impairment. The proteomic data obtained are available at ProteomeXchange with identifier 10.6019/PXD028811. These analyses led to the identification of 560 tear proteins, some of which were deregulated in PD patients and that have been implicated in immune responses, inflammation, apoptosis, collagen degradation, protein synthesis, defense, lipid transport and altered lysosomal function. Of these proteins, six were related to neurodegenerative processes and showed a good capacity to classify patients and controls. These findings revealed that certain proteins were upregulated in the tears of PD patients, mainly proteins involved in lysosomal function. Thus, in this study, tear proteins were identified that are implicated in neurodegeneration and that may be related to an aggressive disease phenotype in PD patients.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2227-7382
2227-7382
DOI:10.3390/proteomes10010004